{"id":"folic-acid-fa","safety":{"commonSideEffects":[{"rate":null,"effect":"Allergic reactions (rare)"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Abdominal distension"},{"rate":null,"effect":"Anorexia"}]},"_chembl":null,"_dailymed":{"setId":"8a359ea4-b9f7-4a4c-ba96-b5c0a38933a9","title":"WESNATE DHA (ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, D-, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, FERROUS FUMARATE, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC SULFATE, AND OMEGA-3 FATTY ACIDS) CAPSULE, GELATIN COATED [WESTMINSTER PHARMACEUTICALS, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Folic acid (vitamin B9) is converted to its active form, tetrahydrofolate, which serves as a carrier of one-carbon units in biosynthetic reactions. It is critical for the synthesis of purines and thymidylate, which are required for DNA replication and cell proliferation. Deficiency leads to impaired cell division and megaloblastic anemia.","oneSentence":"Folic acid is a B vitamin that acts as a coenzyme in one-carbon transfer reactions essential for DNA synthesis and cell division.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:32:39.677Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Folic acid deficiency anemia"},{"name":"Megaloblastic anemia due to folate deficiency"},{"name":"Prophylaxis of neural tube defects in pregnancy"},{"name":"Supplementation in patients on methotrexate or other antifolate drugs"}]},"trialDetails":[{"nctId":"NCT04587128","phase":"PHASE2","title":"Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2020-10-19","conditions":"Metastatic Colorectal Cancer","enrollment":34},{"nctId":"NCT04495088","phase":"PHASE3","title":"Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Ralf Hofheinz","startDate":"2020-09-30","conditions":"Rectal Cancer","enrollment":550},{"nctId":"NCT07295340","phase":"","title":"Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-01-01","conditions":"Liver Cancer","enrollment":20},{"nctId":"NCT03828227","phase":"PHASE3","title":"QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.","status":"ACTIVE_NOT_RECRUITING","sponsor":"GERCOR - Multidisciplinary Oncology Cooperative Group","startDate":"2019-06-14","conditions":"Elderly Patients, Metastatic Colorectal Cancer, Quality of Life","enrollment":49},{"nctId":"NCT05096663","phase":"PHASE2, PHASE3","title":"Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2022-03-15","conditions":"Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8","enrollment":82},{"nctId":"NCT05004350","phase":"PHASE2","title":"A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.","status":"COMPLETED","sponsor":"Pierre Fabre Medicament","startDate":"2021-09-14","conditions":"BRAF V600E, Metastatic Colorectal Cancer","enrollment":107},{"nctId":"NCT03699319","phase":"PHASE1, PHASE2","title":"CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer","status":"COMPLETED","sponsor":"David Bajor, MD","startDate":"2018-12-07","conditions":"Pancreatic Cancer","enrollment":49},{"nctId":"NCT05622591","phase":"PHASE1","title":"ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML","status":"WITHDRAWN","sponsor":"Elucida Oncology","startDate":"2024-06-07","conditions":"Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML","enrollment":""},{"nctId":"NCT05001282","phase":"PHASE1, PHASE2","title":"A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)","status":"TERMINATED","sponsor":"Elucida Oncology","startDate":"2021-09-13","conditions":"Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma","enrollment":79},{"nctId":"NCT06098456","phase":"PHASE2","title":"Epigallocatechin Gallate and Other Antural Compounds in HPV Infections","status":"COMPLETED","sponsor":"Centro di Ricerca Clinica Salentino","startDate":"2023-11-01","conditions":"Papilloma-induced Cervical Lesions","enrollment":178},{"nctId":"NCT04062656","phase":"PHASE2","title":"Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG","status":"UNKNOWN","sponsor":"University Hospital, Essen","startDate":"2019-09-26","conditions":"Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction","enrollment":21},{"nctId":"NCT04617457","phase":"PHASE2","title":"Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas","status":"UNKNOWN","sponsor":"University of Cologne","startDate":"2021-10-10","conditions":"Pancreatic Cancer, Metastasis, Surgery","enrollment":150},{"nctId":"NCT02928224","phase":"PHASE3","title":"Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-10-13","conditions":"BRAF V600E-mutant Metastatic Colorectal Cancer","enrollment":702},{"nctId":"NCT06174883","phase":"","title":"Salt-FA to Increase Folate Levels","status":"COMPLETED","sponsor":"Hydrocephalus and Neuroscience Institute","startDate":"2022-06-01","conditions":"Neural Tube Defects, Folic Acid Deficiency, Spina Bifida","enrollment":80},{"nctId":"NCT02363374","phase":"PHASE2","title":"Induction Chemotherapy Before or After Preoperative Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer","status":"COMPLETED","sponsor":"Prof. Dr. med. Claus Rödel","startDate":"2015-03-25","conditions":"Rectal Neoplasms, Rectal Cancer Stage II, Rectal Cancer Stage III","enrollment":311},{"nctId":"NCT02017704","phase":"PHASE2","title":"Chemoradiation or Brachytherapy for Rectal Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2014-06-12","conditions":"Rectal Cancer","enrollment":9},{"nctId":"NCT01991873","phase":"PHASE2","title":"Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"AIO-Studien-gGmbH","startDate":"2014-04","conditions":"Metastatic Colorectal Cancer","enrollment":387},{"nctId":"NCT05625308","phase":"NA","title":"Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions","status":"COMPLETED","sponsor":"Lo.Li.Pharma s.r.l","startDate":"2022-07-01","conditions":"Papilloma, Cervix Lesion","enrollment":40},{"nctId":"NCT02143219","phase":"PHASE2","title":"Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer","status":"COMPLETED","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2014-07-31","conditions":"Pancreatic Metastatic Cancer, Toxicity","enrollment":72},{"nctId":"NCT04756713","phase":"PHASE3","title":"Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2021-02-11","conditions":"Gestational Trophoblastic Neoplasia, Molar Pregnancy, Gestational Trophoblastic Tumor, Non-Metastatic","enrollment":150},{"nctId":"NCT04037241","phase":"PHASE2, PHASE3","title":"Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases","status":"WITHDRAWN","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2021-11-01","conditions":"Malignant Tumor of Pancreas Metastatic to Liver","enrollment":""},{"nctId":"NCT05291104","phase":"NA","title":"Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression","status":"UNKNOWN","sponsor":"Fu Jen Catholic University Hospital","startDate":"2022-04-01","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":60},{"nctId":"NCT00970866","phase":"NA","title":"Efficacy of Lipid-Based Nutrient Supplements (LNS) for Pregnant and Lactating Women and Their Infants","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2009-11","conditions":"Anemia, Malnutrition, Stunting","enrollment":3499},{"nctId":"NCT00070213","phase":"PHASE3","title":"Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"2003-09","conditions":"Colorectal Cancer","enrollment":460},{"nctId":"NCT03485404","phase":"NA","title":"Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients","status":"TERMINATED","sponsor":"Xijing Hospital","startDate":"2019-01-10","conditions":"Post Operative Cognitive Dysfunction","enrollment":40},{"nctId":"NCT01665378","phase":"NA","title":"Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child Outcomes","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-10","conditions":"Anemia, Intrauterine Growth Retardation, Preterm Delivery","enrollment":5011},{"nctId":"NCT00953134","phase":"EARLY_PHASE1","title":"Periconceptional Iron Supplementation in Rural Bangladesh","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2007-02","conditions":"Anemia","enrollment":273},{"nctId":"NCT04731948","phase":"NA","title":"Vitamin B12 Biomarker Responses to Supplementation","status":"COMPLETED","sponsor":"University of Ulster","startDate":"2004-10-01","conditions":"Healthy","enrollment":200},{"nctId":"NCT01703390","phase":"PHASE2","title":"Biomarker Directed Treatment in Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Arbeitsgemeinschaft medikamentoese Tumortherapie","startDate":"2012-12-04","conditions":"Metastatic Colorectal Cancer","enrollment":47},{"nctId":"NCT01228734","phase":"PHASE3","title":"A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2010-09-09","conditions":"Metastatic Colorectal Cancer","enrollment":553},{"nctId":"NCT01802645","phase":"PHASE2","title":"Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases","status":"UNKNOWN","sponsor":"Technische Universität Dresden","startDate":"2013-03","conditions":"Colorectal Cancer","enrollment":91},{"nctId":"NCT02069041","phase":"PHASE1","title":"A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-04","conditions":"Carcinoma, Hepatocellular","enrollment":8},{"nctId":"NCT03426371","phase":"PHASE3","title":"Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial","status":"UNKNOWN","sponsor":"Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.","startDate":"2018-02","conditions":"Metastatic Colorectal Cancer","enrollment":570},{"nctId":"NCT00154102","phase":"PHASE3","title":"Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-05","conditions":"Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer","enrollment":1221},{"nctId":"NCT02810275","phase":"PHASE3","title":"Folinic Acid: Supplementation and Therapy","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2012-10","conditions":"HIV Infection, HCV Coinfection","enrollment":69},{"nctId":"NCT00835185","phase":"PHASE2","title":"Study of IMC-11F8 in Participants With Colorectal Cancer","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2007-08","conditions":"Metastatic Colorectal Cancer","enrollment":44},{"nctId":"NCT02506231","phase":"PHASE2, PHASE3","title":"The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2015-10","conditions":"Graft vs Host Disease, Allogeneic Hematopoietic Cell Transplantation, Mucositis","enrollment":160},{"nctId":"NCT01362582","phase":"PHASE3","title":"Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer","status":"TERMINATED","sponsor":"National Center for Tumor Diseases, Heidelberg","startDate":"2010-03","conditions":"Pancreatic Cancer","enrollment":32},{"nctId":"NCT00125034","phase":"PHASE2","title":"Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-07","conditions":"Neoplasm Metastasis, Colorectal Cancer","enrollment":344},{"nctId":"NCT00862784","phase":"PHASE2","title":"A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-04","conditions":"Colorectal Carcinoma","enrollment":48},{"nctId":"NCT02066688","phase":"PHASE2, PHASE3","title":"Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2013-01","conditions":"Colorectal Neoplasms","enrollment":2400},{"nctId":"NCT01956786","phase":"PHASE2, PHASE3","title":"Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine","status":"UNKNOWN","sponsor":"Shenzhen Ausa Pharmed Co.,Ltd","startDate":"2013-09","conditions":"Essential Hypertension","enrollment":540},{"nctId":"NCT01851941","phase":"PHASE2","title":"A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2004-10","conditions":"Advanced Gastric Cancer","enrollment":52},{"nctId":"NCT01848873","phase":"PHASE2, PHASE3","title":"Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine","status":"UNKNOWN","sponsor":"Shenzhen Ausa Pharmed Co.,Ltd","startDate":"2013-01","conditions":"Essential Hypertension","enrollment":756},{"nctId":"NCT00289445","phase":"PHASE1, PHASE2","title":"Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"1999-09","conditions":"Gastrointestinal Neoplasms, Neoplasm Metastasis","enrollment":""},{"nctId":"NCT00026273","phase":"PHASE3","title":"Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-01","conditions":"Colorectal Cancer","enrollment":""},{"nctId":"NCT00002722","phase":"PHASE2","title":"High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1996-01","conditions":"Gastric Cancer","enrollment":135},{"nctId":"NCT00291785","phase":"PHASE1, PHASE2","title":"Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer","status":"COMPLETED","sponsor":"CTI BioPharma","startDate":"2004-01","conditions":"Colorectal Cancer","enrollment":48},{"nctId":"NCT01212718","phase":"PHASE2","title":"Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase","status":"COMPLETED","sponsor":"University of Ulm","startDate":"2001-07","conditions":"Colorectal Cancer, Non Resectable Metastasis, Reference Lesion","enrollment":168},{"nctId":"NCT00143403","phase":"PHASE3","title":"Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-12","conditions":"Colorectal Neoplasms, Liver Neoplasms","enrollment":321},{"nctId":"NCT01123811","phase":"PHASE2","title":"Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer","status":"COMPLETED","sponsor":"Johannes Gutenberg University Mainz","startDate":"2006-05","conditions":"Adenocarcinoma of Stomach or Esophagogastric Junction","enrollment":45},{"nctId":"NCT00782041","phase":"PHASE2","title":"Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer","status":"TERMINATED","sponsor":"Sanofi","startDate":"2003-01","conditions":"Uterine Neoplasms","enrollment":11},{"nctId":"NCT00422773","phase":"PHASE1, PHASE2","title":"Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Technische Universität Dresden","startDate":"2007-01","conditions":"Metastatic Colorectal Cancer","enrollment":21},{"nctId":"NCT00153998","phase":"PHASE2","title":"Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)","status":"COMPLETED","sponsor":"Technische Universität Dresden","startDate":"2004-11","conditions":"Colorectal Cancer, Liver Metastases","enrollment":135},{"nctId":"NCT00212589","phase":"PHASE3","title":"Patients Preference for Oral or i.v. Therapy","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2002-12","conditions":"Colorectal Cancer","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3188,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Leucovorin"],"phase":"marketed","status":"active","brandName":"Folic acid (FA)","genericName":"Folic acid (FA)","companyName":"University Hospital, Essen","companyId":"university-hospital-essen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Folic acid is a B vitamin that acts as a coenzyme in one-carbon transfer reactions essential for DNA synthesis and cell division. Used for Folic acid deficiency anemia, Megaloblastic anemia due to folate deficiency, Prophylaxis of neural tube defects in pregnancy.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}